Plustick Management LLC Takes Position in Zymergen Inc. (NASDAQ:ZY)

Plustick Management LLC bought a new position in Zymergen Inc. (NASDAQ:ZYGet Rating) during the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm bought 700,000 shares of the company’s stock, valued at approximately $861,000. Zymergen comprises approximately 0.7% of Plustick Management LLC’s investment portfolio, making the stock its 19th biggest position.

Other large investors have also added to or reduced their stakes in the company. Handelsbanken Fonder AB purchased a new stake in Zymergen during the fourth quarter valued at approximately $236,000. ARCH Venture Management LLC bought a new stake in shares of Zymergen during the 4th quarter valued at $797,000. Data Collective II GP LLC purchased a new position in shares of Zymergen during the 4th quarter valued at $16,383,000. JPMorgan Chase & Co. increased its stake in Zymergen by 2.6% in the 4th quarter. JPMorgan Chase & Co. now owns 3,563,435 shares of the company’s stock worth $23,839,000 after buying an additional 91,260 shares in the last quarter. Finally, Northern Trust Corp raised its holdings in Zymergen by 258.4% during the fourth quarter. Northern Trust Corp now owns 590,227 shares of the company’s stock valued at $3,949,000 after acquiring an additional 425,549 shares during the period. Institutional investors own 68.40% of the company’s stock.

Analyst Upgrades and Downgrades

A number of equities analysts have recently weighed in on ZY shares. UBS Group dropped their price objective on Zymergen to $2.60 in a research note on Tuesday, July 26th. JPMorgan Chase & Co. raised shares of Zymergen from an “underweight” rating to a “neutral” rating in a report on Tuesday, July 26th. Six research analysts have rated the stock with a hold rating, According to MarketBeat, Zymergen presently has a consensus rating of “Hold” and a consensus price target of $6.28.

Zymergen Price Performance

Shares of Zymergen stock traded down $0.35 during trading hours on Wednesday, reaching $3.02. The company’s stock had a trading volume of 34,955 shares, compared to its average volume of 2,218,975. Zymergen Inc. has a one year low of $1.10 and a one year high of $14.68. The firm has a 50 day moving average price of $1.98 and a 200-day moving average price of $2.45. The stock has a market cap of $311.48 million, a P/E ratio of -0.83 and a beta of 2.83.

Zymergen Profile

(Get Rating)

Zymergen Inc design, develop, and commercialize microbes, molecules, and materials. It offers an automation solution comprising reconfigurable automation carts, a modular hardware building blocks that allow for assembly of work cells customized for the particular needs of a lab; and automation control software, a cloud-based software used to control integrated automation systems.

Featured Stories

Want to see what other hedge funds are holding ZY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Zymergen Inc. (NASDAQ:ZYGet Rating).

Institutional Ownership by Quarter for Zymergen (NASDAQ:ZY)

Receive News & Ratings for Zymergen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zymergen and related companies with MarketBeat.com's FREE daily email newsletter.